MiNK Therapeutics, Inc. (INKT) — Institutional Holders, Q2 2026
27 institutional investment managers reported a INKT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $2.4M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
INKT in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- DnB Asset Management ASNew · +55,142 sh+$644.6K
- CITADEL ADVISORSNew · +15,440 sh+$180.5K
- VANGUARD CAPITAL MANAGEMENTAdded · +9,296 sh+$108.7K
- BlackRockAdded · +7,179 sh+$83.9K
- US BANCORP \DE\New · +1,995 sh+$23.3K
Biggest sellers
- UBS Group AGTrimmed · -10,317 sh-$120.6K
- GEODE CAPITAL MANAGEMENTTrimmed · -1,772 sh-$20.7K
- Annis Gardner Whiting Capital AdvisorsSold out · -200 sh-$2.3K
- CITIGROUPSold out · -91 sh-$1.1K
- Pinnacle Wealth Planning ServicesSold out · -5 sh-$58.00
INKT 13F holders ranked 1–27 of 27
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT#1 · 68,660 sh | 68,660 | $802.6K | 0.00% | +15.7% |
| 2 | DnB Asset Management AS#2 · 55,142 sh | 55,142 | $644.6K | <0.01% | New |
| 3 | Longbow Finance SA#3 · 16,667 sh | 16,667 | $194.8K | 0.02% | 0.0% |
| 4 | GEODE CAPITAL MANAGEMENT#4 · 15,573 sh | 15,573 | $182.1K | 0.00% | -10.2% |
| 5 | CITADEL ADVISORS#5 · 15,440 sh | 15,440 | $180.5K | 0.00% | New |
| 6 | BlackRock#6 · 13,382 sh | 13,382 | $156.4K | 0.00% | +115.7% |
| 7 | VANGUARD FIDUCIARY#7 · 8,287 sh | 8,287 | $96.9K | 0.00% | 0.0% |
| 8 | UBS Group AG#8 · 4,885 sh | 4,885 | $57.1K | 0.00% | -67.9% |
| 9 | Steward Partners Investment Advisory#9 · 2,000 sh | 2,000 | $23.4K | <0.01% | 0.0% |
| 10 | US BANCORP \DE\#10 · 1,995 sh | 1,995 | $23.3K | 0.00% | New |
| 11 | Paladin Partners#11 · 1,000 sh | 1,000 | $11.7K | — | 0.0% |
| 12 | Federation des caisses Desjardins du Quebec#12 · 500 sh | 500 | $5.8K | 0.00% | New |
| 13 | Tower Research Capital (TRC)#13 · 422 sh | 422 | $4.9K | <0.01% | +170.5% |
| 14 | OSAIC#14 · 117 sh | 117 | $1.4K | 0.00% | New |
| 15 | MORGAN STANLEY#15 · 113 sh | 113 | $1.3K | 0.00% | +8.7% |
| 16 | Covestor Ltd#16 · 119 sh | 119 | $1.0K | <0.01% | 0.0% |
| 17 | BARCLAYS PLC#17 · 24 sh | 24 | $281.00 | 0.00% | New |
| 18 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT#18 · 18 sh | 18 | $210.00 | 0.00% | 0.0% |
| 19 | Caitong International Asset Management , Ltd#19 · 18 sh | 18 | $210.00 | 0.00% | +80.0% |
| 20 | Game Plan Financial Advisors#20 · 16 sh | 16 | $187.00 | <0.01% | 0.0% |
| 21 | Clearstead Advisors#21 · 14 sh | 14 | $164.00 | 0.00% | 0.0% |
| 22 | BNP PARIBAS FINANCIAL MARKETS#22 · 13 sh | 13 | $152.00 | 0.00% | -18.8% |
| 23 | JPMORGAN CHASE#23 · 9 sh | 9 | $107.00 | 0.00% | 0.0% |
| 24 | Key FInancial#24 · 4 sh | 4 | $47.00 | 0.00% | 0.0% |
| 25 | LifeSteps Financial#25 · 2 sh | 2 | $23.00 | — | New |
| 26 | WELLS FARGO & COMPANY#26 · 2 sh | 2 | $23.00 | 0.00% | New |
| 27 | JONES FINANCIAL COMPANIES LLLP#27 · 1 sh | 1 | $12.00 | 0.00% | 0.0% |
Funds that sold out of INKT in Q2 2026 (3)
Held INKT at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Annis Gardner Whiting Capital Advisors200 sh | 200 | $2.1K |
| CITIGROUP91 sh | 91 | $958.00 |
| Pinnacle Wealth Planning Services5 sh | 5 | $53.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.